Establishment Labs Holdings IncESTA
Price$63.04Intrinsic value$69.5310% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $245.8M+48.1% YoYTTM through 30 Jun 2026
Net Income -$38.9MTTM through 30 Jun 2026
Free Cash Flow -$41.5MTTM through 30 Jun 2026

Margins

Current
Gross Margin70.7%
EBITDA Margin-5.1%
Operating Margin-10.9%
Net Margin-15.8%

Returns

-180.0%ROE
-11.1%ROA

Balance Sheet Health

Debt / Equity12.57x
Current Ratio3.84x
Net Debt$200.5M
Cash & Equivalents$71.2M

Quality Metrics

Altman Z-Score2.88
Piotroski F-Score5 / 9
FCF Margin-16.9%
Rule of 40-7.0
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $211.1M
Diluted EPS-$1.27TTM
'19'20'21'22'23'24'25
FY2025: $-1.72

Dividend

No dividend

Capital Allocation

R&D Spend$20.3M
Capex Intensity3.7%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.